A Comparative Study to Assess the Effect of Vildagliptin Versus Glimepiride on Glucose Variability in Type 2 Diabetic Patients Uncontrolled on Metformin Alone
Phase of Trial: Phase IV
Latest Information Update: 12 Nov 2019
Price : $35 *
At a glance
- Drugs Vildagliptin (Primary) ; Glimepiride; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms VARIABLE
- Sponsors Novartis
- 27 Oct 2015 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 03 Jun 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 07 Jul 2014 Planned End Date changed from 1 Nov 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov record.